Cord Blood Transplantation

One of three foundations of blood-forming cells used in transplants is Cord Blood whereas the other two bases are bone marrow and peripheral blood stem cells.

The inoculation of umbilical cord blood to re-establish an individual's own blood production system blocked by anticancer drugs, radiation therapy, or both. Human cryopreserved CD34+ cells from cord blood, bone marrow, and mobilized blood. CD34+ cells differentiate into all other white blood cells. More Cells. Relevant Results. Types: Cells, Media, Assays. Cancers can be treated through Stem cell transplants, including peripheral blood, bone marrow, and cord blood transplants. The first successful cord blood transplant (CBT) was done in 1988 in a child with Fanconi Anemia. The theory of the learning is twofold unit umbilical cord blood transplantation in adults will be connected with a one-year endurance rate of at least 40%.


  • Human Leukocyte Antigen (HLA) Matching
  • Graft-Versus-Host Disease
  • Diversity
  • Infectious Disease Transmission
  • Clinical Data
  • Engraftment
  • Storage
  • Research and Clinical Trials

Related Conference of Cord Blood Transplantation

August 07-08, 2020

World Summit on Hematology and Cell Therapy

Osaka, Japan
November 15-16, 2020

World Hematology 2020

Paris, France
November 23-24, 2020

Annual Hematology Congress

Dubai, UAE
March 15-16, 2021

19th World Hematology Congress

Berlin, Germany

Cord Blood Transplantation Conference Speakers